Biktarvy, formally known as bictegravir sulfate, includes a effective single-tablet regimen for controlling HIV infection. This formula integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to multiply within the body, considerably reducing the viral burden. For m